Nippon Shinyaku
Update in progress4516.T (Tokyo)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and functional foods in Japan and worldwide. The company operates through Pharmaceuticals and Functional Food segments. It offers medicines for urology, hematology, intractable and rare diseases, gynecology, and other areas, plus health food ingredients, preservatives, protein preparations, and supplements. It is developing ATSN-10 for GUCY2D-mutant Leber congenital amaurosis and RGX-121 for mucopolysaccharidosis. Founded 1911, headquartered in Kyoto.
Company score
- Sentiment
- 0.06
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.29
- Governance
- -0.11
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.06
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.06
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketTokyo (JPX)
- LocationJapan
- Founded1911
- Employees2,309
- Websitewww.nippon-shinyaku.co.jp
Identifiers
- ISINJP3717600005